Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Virulence|June 13, 2020
A novel biosafety level 2 compliant tuberculosis infection model using a ΔleuDΔpanCD double auxotroph of Mycobacterium tuberculosis H37Rv and Galleria mellonellaMasanori Asai, Yanwen Li, John Spiropoulos, et al.Journal of Visualized Experiments : Jove|July 16, 2019
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis ComplexMasanori Asai, Yanwen Li, Jasmeet Singh Khara, et al.FEMS Microbiology Ecology|January 21, 2017
Interlaboratory quantification of Bacteria and Archaea in deeply buried sediments of the Baltic Sea (IODP Expedition 347)Joy Buongiorno, Stephanie Turner, Gordon Webster, et al.Molecular Oncology|April 11, 2024
TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancerShohei Yoshida, Daisuke Kajiwara, Masanao Seki, et al.Virulence|September 2, 2022
Galleria mellonella as an infection model for the virulent Mycobacterium tuberculosis H37RvMasanori Asai, Yanwen Li, John Spiropoulos, et al.Virulence|August 2, 2018
Galleria mellonella - a novel infection model for the Mycobacterium tuberculosis complexYanwen Li, John Spiropoulos, William Cooley, et al.Bioorganic & Medicinal Chemistry Letters|April 29, 2009
Optimization of benzimidazole series as opioid receptor-like 1 (ORL1) antagonists: SAR study directed toward improvement of selectivity over hERG activityKensuke Kobayashi, Tetsuya Kato, Izumi Yamamoto, et al.Bioorganic & Medicinal Chemistry Letters|May 19, 2009
Discovery of novel arylpyrazole series as potent and selective opioid receptor-like 1 (ORL1) antagonistsKensuke Kobayashi, Minaho Uchiyama, Hirokatsu Ito, et al.The Lancet. Infectious Diseases|September 15, 2019
Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyNicola N Lynskey, Elita Jauneikaite, Ho Kwong Li, et al.ACS Omega|January 8, 2026
[Fe(phen) 3 ] 2+ and [Fe(phen) 3 ] 2+ -Loaded Nanostructured Lipid System: In Silico, In Vitro, and In Vivo Efficacy against Mycobacterium tuberculosisFernanda Manaia Demarqui, Christian Shleider Carnero Canales, Rachel Temperani Amaral Machado, et al.Pageof 3